 |
| Heike Galbraith |
Heike Galbraith, who was GCI Health's European policy & PA head, has joined Dentons Global Advisors as a partner based in Brussels.
During her more than 20-year career, Galbraith gained experiences in therapeutic areas including vaccines, oncology, rare diseases, HIV/AIDS and hepatitis.
She did a 12-year stint at Pfizer as director of the global rare disease & vaccines PA team, and head of EU government affairs.
Earlier, Galbraith was director of international government affairs at Gilead and staffer at Burson-Marsteller.
"Heike brings fresh insight and corporate experience on some of the most critical health policy issues facing companies that are looking to make a positive contribution to society," said Grégoire Poisson, CEO of Dentons Global Advisors Interel, the firm's EU PA arm.
The public sentiment surrounding the tragic murder of UnitedHealthcare CEO Brian Thompson reveals the deep-seated resentment the American public harbors toward a health system they feel has abandoned them.
Elevance Health, the big Indianapolis-based healthcare insurer formerly known as Anthem, has hired Nathan Rich as VP-investor relations, effective Nov. 11.
Healthcare organizations can empower patients and build trust in an informational ecosystem where consumers are constantly forced to decipher fact from fiction.
Texas is emerging as a successful contender for federal and global biotechnology funding, and state government support for medical excellence is just one of several reasons why.
How communicators can leverage online information preferences to engage multigenerational health audiences.
Have a comment? Send it to 
No comments have been submitted for this story yet.